US Stock MarketDetailed Quotes

ITOS ITeos Therapeutics

Watchlist
  • 8.330
  • -0.010-0.12%
Trading Dec 4 10:28 ET
304.33MMarket Cap-2652P/E (TTM)

ITeos Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-10.21%-37.35M
-14.83%-33.93M
-22.01%-32.4M
6.69%-103.76M
49.34%-13.77M
-14.12%-33.89M
2.56%-29.55M
-10.64%-26.56M
-121.67%-111.19M
53.80%-27.17M
Net income from continuing operations
-40.69%-45.36M
79.22%-7.13M
-145.75%-38.22M
-216.54%-112.64M
-249.37%-30.55M
-3,353.28%-32.24M
-709.67%-34.3M
-122.35%-15.55M
-54.95%96.65M
-88.94%20.45M
Depreciation and amortization
34.82%302K
37.78%310K
36.94%304K
11.83%898K
1.79%227K
9.27%224K
15.38%225K
23.33%222K
33.17%803K
47.68%223K
Other non cash items
---4K
---4K
-150.00%-1K
----
----
----
----
0.00%2K
-16.67%10K
50.00%3K
Change In working capital
126.10%1.64M
-32,159.41%-32.38M
106.98%990K
96.15%-8.8M
122.21%11.55M
82.88%-6.27M
100.24%101K
85.52%-14.18M
-180.40%-228.49M
79.02%-52.01M
-Change in receivables
81.09%-574K
-899.36%-37.35M
-78.09%384K
-172.50%-7.32M
-160.62%-2.3M
-249.25%-3.04M
-545.42%-3.74M
-77.38%1.75M
192.72%10.1M
164.71%3.79M
-Change in prepaid assets
92.65%-173K
-269.28%-799K
-209.57%-252K
-68.81%184K
737.85%1.84M
32.37%-2.36M
-81.49%472K
-87.29%230K
105.00%590K
94.75%-288K
-Change in payables and accrued expense
297.27%1.52M
46.77%4.27M
114.61%647K
43.04%8.38M
33,440.63%10.67M
93.17%-768K
110.50%2.91M
-109.88%-4.43M
-52.14%5.86M
-101.08%-32K
-Change in other working capital
881.98%868K
226.09%1.5M
101.80%211K
95.90%-10.04M
102.43%1.35M
99.47%-111K
102.84%460K
92.29%-11.74M
-183.16%-245.03M
76.83%-55.48M
Cash from discontinued investing activities
Operating cash flow
-10.21%-37.35M
-14.83%-33.93M
-22.01%-32.4M
6.69%-103.76M
49.34%-13.77M
-14.12%-33.89M
2.56%-29.55M
-10.64%-26.56M
-121.67%-111.19M
53.80%-27.17M
Investing cash flow
Cash flow from continuing investing activities
-503.16%-91.49M
-18.81%16.32M
-119.60%-69.6M
116.29%72.66M
113.83%61.56M
21,712.38%22.69M
4,011.09%20.1M
-9,712.38%-31.69M
-35,814.81%-446.06M
-276,372.05%-445.12M
Net PPE purchase and sale
87.48%-94K
36.86%-442K
-694.12%-945K
-216.20%-2.97M
-1,093.16%-1.4M
-804.82%-751K
-36.99%-700K
47.58%-119K
20.58%-938K
27.78%-117K
Net investment purchase and sale
-488.47%-91.4M
-19.42%16.76M
-117.43%-68.66M
117.02%75.72M
114.15%62.97M
--23.53M
--20.8M
---31.58M
---445M
---445M
Net other investing changes
----
----
----
17.50%-99K
-1,700.00%-16K
----
----
----
-96.72%-120K
0.00%1K
Cash from discontinued investing activities
Investing cash flow
-503.16%-91.49M
-18.81%16.32M
-119.60%-69.6M
116.29%72.66M
113.83%61.56M
21,712.38%22.69M
4,011.09%20.1M
-9,712.38%-31.69M
-35,814.81%-446.06M
-276,372.05%-445.12M
Financing cash flow
Cash flow from continuing financing activities
-4,520.00%-442K
56,035.78%122.38M
-96.19%22K
-43.90%1.11M
-77.66%307K
1,100.00%10K
-21.58%218K
73.57%578K
-45.78%1.98M
-41.68%1.37M
Net common stock issuance
--0
----
----
----
----
----
----
----
----
----
Proceeds from stock option exercised by employees
360.00%46K
992.66%2.38M
-96.19%22K
20.32%1.11M
-2.54%307K
1,100.00%10K
-21.58%218K
73.57%578K
-68.57%925K
-80.79%315K
Net other financing activities
----
----
----
----
----
----
----
----
47.91%1.06M
----
Cash from discontinued financing activities
Financing cash flow
-4,520.00%-442K
56,035.78%122.38M
-96.19%22K
-43.90%1.11M
-77.66%307K
1,100.00%10K
-21.58%218K
73.57%578K
-45.78%1.98M
-41.68%1.37M
Net cash flow
Beginning cash position
16.13%251.4M
-34.88%146.92M
-11.78%251.45M
-66.42%285.04M
-72.84%204.4M
-72.67%216.48M
-72.63%225.6M
-66.42%285.04M
152.29%848.84M
-16.38%752.47M
Current changes in cash
-1,055.65%-129.28M
1,235.73%104.77M
-76.83%-101.98M
94.60%-29.99M
110.21%48.1M
62.46%-11.19M
69.81%-9.23M
-140.38%-57.67M
-207.70%-555.27M
-731.70%-470.92M
Effect of exchange rate changes
316.20%1.94M
-358.04%-289K
-44.21%-2.55M
57.75%-3.6M
-130.05%-1.05M
90.94%-895K
107.13%112K
-214.56%-1.77M
-168.45%-8.53M
-37.18%3.49M
End cash Position
-39.31%124.05M
16.13%251.4M
-34.88%146.92M
-11.78%251.45M
-11.78%251.45M
-72.84%204.4M
-72.67%216.48M
-72.63%225.6M
-66.42%285.04M
-66.42%285.04M
Free cash flow
-8.09%-37.45M
-13.63%-34.37M
-25.01%-33.35M
4.82%-106.72M
44.44%-15.16M
-16.33%-34.64M
1.90%-30.25M
-10.09%-26.67M
-121.90%-112.13M
53.73%-27.29M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -10.21%-37.35M-14.83%-33.93M-22.01%-32.4M6.69%-103.76M49.34%-13.77M-14.12%-33.89M2.56%-29.55M-10.64%-26.56M-121.67%-111.19M53.80%-27.17M
Net income from continuing operations -40.69%-45.36M79.22%-7.13M-145.75%-38.22M-216.54%-112.64M-249.37%-30.55M-3,353.28%-32.24M-709.67%-34.3M-122.35%-15.55M-54.95%96.65M-88.94%20.45M
Depreciation and amortization 34.82%302K37.78%310K36.94%304K11.83%898K1.79%227K9.27%224K15.38%225K23.33%222K33.17%803K47.68%223K
Other non cash items ---4K---4K-150.00%-1K----------------0.00%2K-16.67%10K50.00%3K
Change In working capital 126.10%1.64M-32,159.41%-32.38M106.98%990K96.15%-8.8M122.21%11.55M82.88%-6.27M100.24%101K85.52%-14.18M-180.40%-228.49M79.02%-52.01M
-Change in receivables 81.09%-574K-899.36%-37.35M-78.09%384K-172.50%-7.32M-160.62%-2.3M-249.25%-3.04M-545.42%-3.74M-77.38%1.75M192.72%10.1M164.71%3.79M
-Change in prepaid assets 92.65%-173K-269.28%-799K-209.57%-252K-68.81%184K737.85%1.84M32.37%-2.36M-81.49%472K-87.29%230K105.00%590K94.75%-288K
-Change in payables and accrued expense 297.27%1.52M46.77%4.27M114.61%647K43.04%8.38M33,440.63%10.67M93.17%-768K110.50%2.91M-109.88%-4.43M-52.14%5.86M-101.08%-32K
-Change in other working capital 881.98%868K226.09%1.5M101.80%211K95.90%-10.04M102.43%1.35M99.47%-111K102.84%460K92.29%-11.74M-183.16%-245.03M76.83%-55.48M
Cash from discontinued investing activities
Operating cash flow -10.21%-37.35M-14.83%-33.93M-22.01%-32.4M6.69%-103.76M49.34%-13.77M-14.12%-33.89M2.56%-29.55M-10.64%-26.56M-121.67%-111.19M53.80%-27.17M
Investing cash flow
Cash flow from continuing investing activities -503.16%-91.49M-18.81%16.32M-119.60%-69.6M116.29%72.66M113.83%61.56M21,712.38%22.69M4,011.09%20.1M-9,712.38%-31.69M-35,814.81%-446.06M-276,372.05%-445.12M
Net PPE purchase and sale 87.48%-94K36.86%-442K-694.12%-945K-216.20%-2.97M-1,093.16%-1.4M-804.82%-751K-36.99%-700K47.58%-119K20.58%-938K27.78%-117K
Net investment purchase and sale -488.47%-91.4M-19.42%16.76M-117.43%-68.66M117.02%75.72M114.15%62.97M--23.53M--20.8M---31.58M---445M---445M
Net other investing changes ------------17.50%-99K-1,700.00%-16K-------------96.72%-120K0.00%1K
Cash from discontinued investing activities
Investing cash flow -503.16%-91.49M-18.81%16.32M-119.60%-69.6M116.29%72.66M113.83%61.56M21,712.38%22.69M4,011.09%20.1M-9,712.38%-31.69M-35,814.81%-446.06M-276,372.05%-445.12M
Financing cash flow
Cash flow from continuing financing activities -4,520.00%-442K56,035.78%122.38M-96.19%22K-43.90%1.11M-77.66%307K1,100.00%10K-21.58%218K73.57%578K-45.78%1.98M-41.68%1.37M
Net common stock issuance --0------------------------------------
Proceeds from stock option exercised by employees 360.00%46K992.66%2.38M-96.19%22K20.32%1.11M-2.54%307K1,100.00%10K-21.58%218K73.57%578K-68.57%925K-80.79%315K
Net other financing activities --------------------------------47.91%1.06M----
Cash from discontinued financing activities
Financing cash flow -4,520.00%-442K56,035.78%122.38M-96.19%22K-43.90%1.11M-77.66%307K1,100.00%10K-21.58%218K73.57%578K-45.78%1.98M-41.68%1.37M
Net cash flow
Beginning cash position 16.13%251.4M-34.88%146.92M-11.78%251.45M-66.42%285.04M-72.84%204.4M-72.67%216.48M-72.63%225.6M-66.42%285.04M152.29%848.84M-16.38%752.47M
Current changes in cash -1,055.65%-129.28M1,235.73%104.77M-76.83%-101.98M94.60%-29.99M110.21%48.1M62.46%-11.19M69.81%-9.23M-140.38%-57.67M-207.70%-555.27M-731.70%-470.92M
Effect of exchange rate changes 316.20%1.94M-358.04%-289K-44.21%-2.55M57.75%-3.6M-130.05%-1.05M90.94%-895K107.13%112K-214.56%-1.77M-168.45%-8.53M-37.18%3.49M
End cash Position -39.31%124.05M16.13%251.4M-34.88%146.92M-11.78%251.45M-11.78%251.45M-72.84%204.4M-72.67%216.48M-72.63%225.6M-66.42%285.04M-66.42%285.04M
Free cash flow -8.09%-37.45M-13.63%-34.37M-25.01%-33.35M4.82%-106.72M44.44%-15.16M-16.33%-34.64M1.90%-30.25M-10.09%-26.67M-121.90%-112.13M53.73%-27.29M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----------------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Symbol Mini Chart % Chg
Salesforce
CRM
+9.05%
Adobe
ADBE
+4.03%
Coinbase
COIN
+3.78%
Oracle
ORCL
+2.65%
Amazon
AMZN
+2.52%

Unlock the Full List